Navinci Featured in BioStock

Uppsala, Sweden – October 29, 2025 – Navinci has been featured in an article by BioStock highlighting the company’s unique technology and future ambitions.

The article includes an in-depth interview with CEO Jenny Sundqvist, who discusses Navinci’s innovative approach to mapping protein interactions directly in tissue and cell samples - revealing how proteins function together in their native context.

The article also highlights Navinci’s legacy, consistent double-digit growth, expanding product portfolio, and ongoing investment in multiplexing and spatial biology technologies.

Read the full article on BioStock here:

https://biostock.se/en/2025/10/navincis-vd-om-tekniken-vi-visar-hur-proteiner-verkligen-samverkar/

For further information, please contact:

Jenny Sundqvist, CEO

E-mail: jenny.sundqvist@navinci.se

About Navinci

Navinci is a Swedish biotech company specializing in developing innovative solutions for studying in situ protein expression and interactions. With a focus and a strong legacy in developing in situ proximity ligation assay technology, Navinci has established itself as a center of excellence in the field and has a broad portfolio of products that help researchers study protein interactions in depth.